Targeting USP10–FAK pathway sensitizes BCR-ABL+ leukemia cells to tyrosine kinase inhibitors
2025 · Cell investigation. · 9 citations
https://doi.org/10.1016/j.clnves.2025.100017
K
Kangjie Qiu
Jinan University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
108
Citations
4
h-index
2
i10-index
Kangjie Qiu is an academic researcher from Jinan University. The author has contributed to research in topics: Ferroptosis and cancer prognosis & Drug Transport and Resistance Mechanisms & RNA modifications and cancer. The author has an h-index of 4, co-authored 10 publications.
Papers by this author
worksTargeting HSPA8 to repress GPX4 and induce ferroptosis in BCR-ABL positive leukemia
2025 · Biomedical Technology · 4 citations
https://doi.org/10.1016/j.bmt.2025.100088
Additional file 4 of Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.22914686
Additional file 3 of Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.22914683
Additional file 2 of Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.22914680
METTL16 in cancer: Roles and regulatory mechanisms
2025 · Genes & Diseases · 0 citations
https://doi.org/10.1016/j.gendis.2025.101758
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat